fall

Michael Vi/iStock Editorial via Getty Images Biotechs developing a class of novel cancer drugs called anti-TIGIT therapies turned lower in the premarket Friday after a similar drug developed by Roche (OTCQX:RHHBY) failed in a Phase 2/3 clinical trial. Roche (OTCQX:RHHBY) shares fell in European trading on Thursday after the SwissContinue Reading

ultramarinfoto/E+ via Getty Images Alvopetro Energy (OTCQX:ALVOF) Wednesday reported June sales volumes of 1,669 boepd including natural gas sales of 9.6 MMcfpd, associated natural gas liquids sales from condensate of 67 bopd and oil sales of 10 bopd, based on field estimates. Q2 sales averaged 1,629 boepd compared to 1,701 boepdContinue Reading